The purpose of this Phase I open label study is to evaluate longer term tolerability and potential effectiveness of transcranial ultrasound in people with tremor as a results of Parkinson's Disease or Essential Tremor.
Tremor, Parkinson Disease, Essential Tremor
The purpose of this Phase I open label study is to evaluate longer term tolerability and potential effectiveness of transcranial ultrasound in people with tremor as a results of Parkinson's Disease or Essential Tremor.
Open Label Study for the Use of Transcranial Ultrasound Treatment of Tremor
-
Neurological Associates of West Los Angeles, Los Angeles, California, United States, 90403
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 90 Years
ALL
No
Neurological Associates of West Los Angeles,
Sheldon Jordan, MD, PRINCIPAL_INVESTIGATOR, The Regenesis Project
2024-08-13